We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

COVID-19 Vaccine Development: An Interview With GeoVax
Industry Insight

Technology Networks spoke with David Dodd, President and CEO of GeoVax, to learn more about the vaccine candidates against COVID-19, what progress has been made in clinical testing and how the company is working to accelerate vaccine development timeframes.

Read More

Degassing Technology That Could Improve HPLC and Laboratory Efficiency
Industry Insight

In the world of analytical chemistry, liquid chromatography has become indispensable in the analyst’s toolbox. Decades of research and refinement have brought many advances, which begs the question, where else can improvements be made?

Read More

Less Time Managing Inventory, More Time at the Bench? Yes Please
Industry Insight

Lab efficiency is critical to speeding up development processes, yet many researchers find they spend more time managing consumables data than working at the bench. Lab informatics is one solution to this problem.

Read More

Out of Academia a Sensor Star Is Born
Industry Insight

As technology becomes smarter and smaller, scientists and engineers are looking to miniaturize and mobilize the testing required to keep our industries going. One such company, Lantha Sensors, was born out of academic research into new metal organic frameworks.

Read More

Sartorius Supports COVID-19 Vaccine Development Efforts
Industry Insight

Technology Networks spoke with Amelie Boulais, Vaccine Marketing Manager, Sartorius, to find out more about how Sartorius is supporting vaccine development at this critical time and the power of collaboration.

Read More

COVID-19 Vaccine Development Update: An Interview With Novavax
Industry Insight

Technology Networks recently had the pleasure of speaking with Novavax to discuss their current progress in COVID-19 vaccine development.

Read More

Remdesivir and Sarilumab – COVID-19 Clinical Trials Begin
Industry Insight

The Feinstein Institutes is collaborating with Gilead Sciences and Regeneron Pharmaceuticals in an effort to identify effective therapeutic treatments against COVID-19. Technology Networks recently had the pleasure of speaking with Kevin Tracey, CEO and President of the Feinstein Institutes for Medical Research to find out more.

Read More

Advancing ALS Research With Omics Analysis Technology
Industry Insight

Clinical trials produce a massive amount of medically relevant and highly sensitive data. Leveraging such data could make a difference to efforts to create more personalized, effective medicines. We talked to Medidata’s Sheila Diamond to find out more.

Read More

Antibody To Treat Lung Inflammation May Offer Potential in COVID-19
Industry Insight

Early stage biotech company Aqualung Therapeutics is currently developing a therapeutic monoclonal antibody – ALT-100 – for the treatment of unchecked inflammation. COVID-19 can cause severe pneumonia and respiratory failure. There is therefore a potential option to treat patients diagnosed with COVID-19 with ALT-100. Technology Networks recently spoke with Joe Garcia, MD, Founder and Chief Executive Officer of Aqualung Therapeutics to learn more.

Read More

Development of Immunotherapy To Treat COVID-19 in Progress
Industry Insight

CEL-SCI Corporation recently announced that it is utilizing LEAPS peptide technology in efforts to develop an immunotherapy against the novel coronavirus caused by SARS-CoV-2. Technology Networks, spoke with Daniel Zimmerman, Ph.D. Senior VP of Research, Cellular Immunology at CEL-SCI Corporation, to learn more about the LEAPS technology.

Read More

 
Advertisement